EXELIXIS PATENT CO LLC has a total of 30 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are 55PHARMA DRUG DISCOVERY & DEV AG, EPIGEN BIOSCIENCES INC and CALIFORNIA CAPITAL EQUITY LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | New Zealand | 3 | |
#5 | Taiwan | 3 | |
#6 | EAPO (Eurasian Patent Organization) | 2 | |
#7 | Israel | 2 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | Malaysia | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Busch Brett B | 18 |
#2 | Mohan Raju | 18 |
#3 | Martin Richard | 15 |
#4 | Stevens William C Jr | 12 |
#5 | Kick Ellen K | 10 |
#6 | Zhang Haiying | 8 |
#7 | Bollu Venkataiah | 8 |
#8 | Lu Shao-Po | 7 |
#9 | Xie Yinong | 7 |
#10 | Wang Yong | 6 |
Publication | Filing date | Title |
---|---|---|
KR20120047868A | Lxr modulators | |
NZ598251A | 2-Arylamino-pyridopyrimidines and their uses, particularly in the treatment of cancer | |
US2010069367A1 | LXR and FXR modulators | |
AU2005244736A1 | Raf modulators and methods of use |